is a contract research organization CRO, born as a spin–off company, of the University Complutense of Madrid in 2006, from the Research Group «Biochemistry-Pharmacology of the Eye» created by Prof. Jesus Pintor. The company is focused on the exploitation of its scientific experience in the fields of biochemistry, neurochemistry, research on eye diseases, molecular biology, molecular pathology and pharmacology. We are offering to our clients a wide range of «outsourced» pharmaceutical research services to aid in the drug and medical device research & development process. Our services include research related with the physiology of the eye and its diseases. More specifically we possess expertise on: Animal toxicity studies Preclinical trials Clinical trial management (phase I through phase V) Clinical, medical and safety monitoring Preclinical and clinical laboratory services for processing trial samples Data management Pharmacokinetic and pharmacodynamic studies Product development Formulation and manufacturing Biostatistics and medical writing services Quality-Regulatory Studies for ISO validation Recently we were contracted for absorption, distribution, metabolism, and excretion evaluations of medical compounds in «in vivo» models. Our staff is a multidisciplinary team, composed of a group of doctors and other health professionals with many years of basic and applied research experience. Estudios Regulatorios bajo Norma ISO MDR (EU) 2017/745 y IVDR (EU) 2017/746 DETERMINACIÓN DE COMPATIBILIDAD FÍSICA DE SOLUCIONES DE LENTES DE CONTACTO Para determinar la compatibilidad física entre la solución de estudio y las lentes de contacto convencionales de hidrogel, hidrogel de silicona y rígidas permeables a los gases, evaluando los parámetros de las lentes de contacto como: diámetro, potencia, radio, apariencia física y transmitancia espectral. Referencias UNE-EN ISO 11981:2018 UNE-EN ISO 18369-1:2018 UNE-EN ISO 18369-2:2013 UNE-EN ISO 18369-3:2018 UNE-EN ISO 18369